Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Superficial adenopathy. Diagnostic orientation]

P Brice1, C Gisselbrecht

  • 1Hôpital de jour d'hématologie, hôpital Saint-Louis, Paris.

La Revue Du Praticien
|February 1, 1994
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

One-Day Brentuximab-Bendamustine (120 mg/m2) Every 21 Days is a Feasible, Safe and Effective Treatment for Relapsed/Refractory Hodgkin Lymphoma.

Hematological oncology·2024
Same author

Tandem versus single haematopoietic stem cell transplant and BV maintenance in relapsed/refractory Hodgkin lymphoma: A matched cohort analysis from the LYSA.

British journal of haematology·2023
Same author

Correction to: Risk of relapse after anti-PD1 discontinuation in patients with Hodgkin lymphoma.

European journal of nuclear medicine and molecular imaging·2021
Same author

Ambulatory high-dose methotrexate administration as central nervous system prophylaxis in patients with aggressive lymphoma.

Annals of hematology·2021
Same author

Image-guided lymph node core-needle biopsy predicts survival in mycosis fungoides and Sézary syndrome.

The British journal of dermatology·2021
Same author

Risk of relapse after anti-PD1 discontinuation in patients with Hodgkin lymphoma.

European journal of nuclear medicine and molecular imaging·2020